Manufactured in full alignment with cGMP, ISO 22000, and Swiss Food Contaminants Ordinance standards. Offered in customized hard capsules, softgels, and standardized botanical extract concentrates ready for immediate deployment in Zurich, Schlieren, and Basel supply chains.
Standardized marine polyphenols, fucoidan, and naturally bonded trace minerals. Engineered for metabolic endocrine balance and clean-label Swiss thyroid nutrition brands.
Fermented menaquinone-7 (MK-7) paired with Cholecalciferol in microencapsulated beadlet tech for heightened stability against oxidative degradation.
Advanced mitophagy inductors featuring pure Urolithin A combined with Pyrroloquinoline Quinone to stimulate biogenesis in aging mitochondrial networks.
Triple-action neuro-relaxant formula integrating chelated bisglycinate with botanical bioflavonoids for GABA receptor modulation and sleep architecture repair.
Highly specialized chelate proven to cross cerebral spinal fluid thresholds, elevating synaptic density and long-term potentiation in nootropic formulations.
High-potency L-Alpha-Glycerylphosphorylcholine delivering immediate bioavailable choline for acetylcholine synthesis, executive function, and athletic output.
Universal hydrophilic and lipophilic antioxidant matrix fortified with phosphorylated B-vitamins for peripheral neurological maintenance and glucose kinetics.
CO2 supercritical extracted serenoa repens fatty acids paired with phytosterols and natural carotenoid tomato extracts for targeted prostate homeostasis.
Saponins represent an structurally diverse family of naturally occurring amphiphilic glycosides, characterized by a non-polar aglycone core (sapogenin) covalently coupled to one or more polar oligosaccharide moieties via ether or ester glycosidic linkages. Sourced widely across botanical species such as Panax ginseng, Tribulus terrestris, Quillaja saponaria, Camellia oleifera, Yucca schidigera, and Glycyrrhiza glabra, saponins are systematically categorized into two distinct architectural lineages: triterpenoid saponins (primarily pentacyclic oleanane, ursane, or dammarane systems) and steroidal saponins (spirostanol and furostanol skeletons).
For research institutions, phytopharmaceutical developers, and formulation chemists across the Zurich biotechnology cluster (notably within the Schlieren-Zürich biomedical campus and ETH Zurich spin-off hubs), sourcing standardized saponin isolates presents distinct analytical and regulatory hurdles. Natural amphiphilicity confers surface-active foaming properties, selective membrane permeability modification, hemolytic interactions at unrefined grades, and potent micellar encapsulation capabilities. Consequently, commercial batch manufacturing requires precise multi-stage chromatographic purification to eliminate unwanted pyrogenic contaminants, agrochemical residues, and unstable sapogenin isomers while guaranteeing repeatable bioactive batch-to-batch titers.
Factory Qualification Benchmark: Saponin raw material destined for the Swiss market must satisfy the stringent purity mandates codified under the Swiss Federal Food Safety and Veterinary Office (FSVO / BLV) and the Swiss Ordinance on Contaminants in Food (VOS / SR 817.022.15). ESNO Biotech applies high-resolution HPLC-ELSD (Evaporative Light Scattering Detection) and LC-MS/MS testing for every production run, delivering true aglycone/glycoside quantified profiles beyond outdated non-specific UV spectrophotometric colorimetry.
The contemporary Swiss nutraceutical and clean-label cosmetic environment categorically rejects legacy petroleum-derived hydrocarbon solvent extractions. To preserve molecular integrity and safeguard native secondary glycoside linkages, ESNO Biotech employs advanced subcritical water extraction (SWE) combined with state-of-the-art superheated hydro-ethanolic counter-current extraction columns. Downstream processing incorporates macroporous resin fractionation (cross-linked styrene-divinylbenzene matrices), followed by falling-film low-temperature vacuum evaporation and aseptic spray drying inside cleanroom conditions audited to NSF 455-2 GMP guidelines.
| Botanical Source | Predominant Saponin Chemotype | Assay / Standardization | Solvent Medium | Primary Industrial Use (Zurich) |
|---|---|---|---|---|
| Quillaja saponaria Molina | Triterpene Quillaic Acid Glycosides (QS-7, QS-18, QS-21) | Sapindus Saponins ≥ 65% - 90% (HPLC) | Pure Purified Water / Ethanol | Clean-label food emulsifier, vaccine adjuvant R&D |
| Panax notoginseng / Ginseng | Dammarane-type (Ginsenosides Rb1, Rg1, Rd, Re) | Total Ginsenosides ≥ 10% - 80% (HPLC-UV) | Supercritical CO2 + Food Ethanol | Cognitive nootropics, adaptogenic longevity |
| Tribulus terrestris L. | Furostanol & Spirostanol (Protodioscin, Dioscin) | Protodioscin ≥ 20% - 60% (HPLC-ELSD) | Hydro-Ethanolic Azeotrope | Endocrine optimization, sports nutrition |
| Yucca schidigera | Steroidal Saponins (Sarsasapogenin, Smilagenin) | Total Saponins ≥ 30% - 60% (Gravimetric/HPLC) | Water Leach / Concentration | Swiss alpine veterinary feed, ammonia capture |
| Camellia oleifera (Tea Saponin) | Oleanane-type Pentacyclic Triterpenoid Glycosides | Tea Saponin ≥ 60% - 98% (UV/HPLC) | Aqueous Phase Enzymatic | Sulfate-free Swiss dermocosmetics, green surfactants |
Each production batch arrives complete with comprehensive batch records, an exhaustive Certificate of Analysis (COA) confirming residual solvent limits well below ICH Q3C Class 3 thresholds (< 50 ppm ethanol), zero detectable organochlorine or pyrethroid pesticides (< 0.01 mg/kg limits), and negative heavy metal assays (Pb < 0.5 ppm, Cd < 0.1 ppm, Hg < 0.05 ppm, As < 0.5 ppm) tested via Inductively Coupled Plasma Mass Spectrometry (ICP-MS).
How specialized saponin extracts and private-label finished formulations integrate directly into the Canton of Zurich's core industrial sectors, life science ecosystems, and premium consumer channels.
Zurich's natural personal care brand owners leverage our ultra-purified Quillaja and Camellia oleifera saponins to replace synthetic sodium laureth sulfate (SLS) and ethoxylated PEG emulsifiers, yielding velvety, biodegradable micellar cleansing foams and physiological barrier serums.
Schlieren biotech startups and Swiss academic researchers utilize our standardized high-purity fractions (e.g., purified ginsenoside monomers and isolated saponin glycosides) as natural bioactive scaffolds for metabolic signaling, immunomodulatory research, and nanocarrier drug-delivery systems.
Distributors serving Swiss pharmacies and premium retailers require fully packaged OEM capsules. Our plant provides ready-to-shelf lines—such as adaptogenic Ginseng complexes, Tribulus endocrine regulators, and synergistic botanical compounds packaged in recyclable pharmaceutical amber glass.
Swiss sustainable livestock programs rely on our food-grade Yucca schidigera and tea saponins as clean, non-antibiotic feed additives. These specialized natural surfactants reduce enteric rumen methane emissions and naturally optimize digestive tract nitrogen absorption.
Navigating the evolving technical dynamics of Swiss botanical manufacturing, ESG supply chain demands, and heightened compliance parameters.
Swiss consumer demand has catalyzed a strict regulatory aversion to synthetic residual solvents like hexane, methanol, and ethyl acetate. Swiss buyers increasingly demand subcritical water extraction or food-grade azeotropic bio-ethanol processing, with zero tolerance for toxic extraction aids.
Zurich quality control laboratories no longer accept generic UV-spectrophotometry assays for saponin quantification due to false positives from carbohydrate backbones. Purchasing mandates now specify HPLC-ELSD, LC-MS fingerprinted chromatograms, and verified aglycone ratio identification.
Rather than managing fractured supply chains between raw powder importers and local Swiss contract encapsulators, Zurich brand aggregators are adopting direct factory contract manufacturing—demanding custom gelatin or vegan HPMC capsules bottled and labeled directly at the source.
Founded in 2006, we combine 19 years of botanical extraction engineering with internationally audited cleanroom production to supply over 100 countries worldwide.
Specialized botanical extraction, ingredient purification, and custom private label manufacturing operating continuously since 2006.
Dedicated formulation R&D engineering customized active blends, capsule delivery kinetics, and specialized single-serve stick packs.
Trusted supplier to pharmaceutical distributors, botanical importers, cosmetic laboratories, and major e-commerce brands in Europe.
Every single batch is supplied with an exhaustive Certificate of Analysis, heavy-metal screen, pesticide panel, and verified microbiology limits.
Clear, definitive technical answers addressing customs clearance, Swiss regulatory frameworks, analytical quality verification, and factory logistics.
Switzerland enforces some of the world's most stringent limits on pesticide residues, polycyclic aromatic hydrocarbons (PAH4), ethylene oxide (EtO), and heavy metals under the Ordinance of the FDHA on Contaminants in Food (VOS). Our raw botanical harvests are subjected to pre-extraction quarantine inspections. During manufacturing, active charcoal filtration and molecular distillation ensure PAH4 levels remain well below 10 μg/kg for benzo(a)pyrene.
Every shipment bound for Zurich or Basel includes a third-party verifiable Certificate of Analysis detailing multi-residue pesticide screens covering over 500 compounds, all verified non-detectable at quantification limits of 0.01 mg/kg.
Unlike standard suppliers who rely solely on sulfuric acid-vanillin spectrophotometric assays (which often cross-react with non-saponin carbohydrate rings, yielding artificially inflated values), ESNO Biotech validates titers using validated High-Performance Liquid Chromatography coupled with Evaporative Light Scattering Detectors (HPLC-ELSD) or charged aerosol detectors (CAD).
For custom ginsenoside profiles (Rb1, Rg1, Re, Rd), protodioscin, or quillaic acid fractions, reference standard calibration curves from European Pharmacopoeia (Ph. Eur.) reference substances are systematically applied.
For bulk standardized saponin powders (e.g., Quillaja saponin 80%, Ginsenosides 80%, Tribulus Protodioscin 50%), our standard MOQ begins at 1 kg for pilot trial verification and 25 kg (standard fiber drum) for commercial production pricing tiers.
For custom private label OEM projects (including HPMC vegan capsules, enteric softgels, and powder stick packs), our stock formulations start as low as 500 bottles. Fully bespoke, custom-tailored proprietary formula premixes typically commence at 1,000 to 2,000 units depending on active ingredient economics.
We provide a turnkey documentation dossier tailored to the Federal Office for Customs and Border Security (FOCBS / BAZG). This includes: Commercial Invoice and Packing List, Certificate of Origin, Detailed Batch Specific Certificate of Analysis (COA), Allergen Declaration, Non-GMO Certification, TSE/BSE Free Attestation, and Manufacturing Flow Process Charts.
Where required for Swissmedic or cantonal chemist inquiries, we supply technical safety data sheets (MSDS) in English or German, alongside our ISO 22000, NSF 455-2 GMP, and HACCP facility certificates verified by TÜV Rheinland.
Yes. Many natural saponins exhibit an inherent astringent bitterness and foaming tendency that can challenge beverage formulations. Our technical R&D department utilizes microencapsulation technologies and natural cyclodextrin taste-masking complexes.
This allows us to supply instantly soluble, crystal-clear, and organoleptically neutral saponin premixes optimized for functional beverage stick packs, effervescent tablets, and ready-to-drink functional beverages.
For in-stock standardized botanical extracts, dispatch occurs within 3 to 5 business days upon order confirmation. Express air freight directly to Zurich Airport (ZRH) takes approximately 5 to 7 transit days.
For custom private label OEM capsule manufacturing—incorporating customized label printing, secondary outer carton fabrication, encapsulation, and finished product microbial incubation testing—the standard production lifecycle is 3 to 4 weeks following final artwork and pilot sample approval.
Whether you require multi-drum bulk shipments of high-purity saponin active ingredients or a completely finished private label line of capsules tailored for Swiss retail distribution, our bilingual technical account team is standing by to evaluate your specifications, provide pilot trial samples, and issue competitive factory-direct quotations.